 |
36
72 | f
 |
f
|
25
1d
18
8
18
2
8c
1a
8
49
16
19
1
49
0
1b
1d
18
89
39
1d
2 29
1d
25
39
Mona Al Mukaddam, M.D., M.S.
6cProfessor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
55
4
3
3
3
2
4
b
1f
55
3rd floor Penn Medicine University City
35 3737 Market Street
Philadelphia, PA 19104
26
35 3737 Market Street
Philadelphia, PA 19104
2e
Office: 215-662-9905
30
ad
12
30
13
Education:
21 7 BS c
3f American University of Beirut, Lebanon, 2001.
21 7 MD c
3f American University of Beirut, Lebanon, 2005.
21 7 MS c
69 University of Pennsylvania, Institute of Translational Medicine and Therapeutics, 2013.
c
3
27
21 7 BS c
3f American University of Beirut, Lebanon, 2001.
21 7 MD c
3f American University of Beirut, Lebanon, 2005.
21 7 MS c
69 University of Pennsylvania, Institute of Translational Medicine and Therapeutics, 2013.
c
Links
8a Webinar on COVID-19 vaccinations in FOP patients
bf Patient educational Video for Penn Medicine: Journey of osteoporotic patients through falls and fractures
c1 Penn Bone Center
a4 Global CME on treatment considerations in Fibrodysplasia Ossificans Progressiva (FOP)
9e Patient Educational Video at Penn Medicine: Osteoporosis Myths and Facts
be Interviewed for a Penn primary care podcast to discuss osteoporosis
a4 Penn Primary Care Podcast discussing osteoporosis 4e Hosted by Drs Amber Bird, Deepa Rani Nandiwada and Mona Al Mukaddam
a4 Webinar for BMT organization on "Bone Health after Transplant"
a6 CureTalk@penn: How Is Fibrodysplasia Ossificans Progressiva (FOP) First Detected?
121 Report on a patient with a rare bone disease correctly diagnosed at the Penn Bone Center
cd CDC sponsored virtual grand round on evaluation and management of bone health in patients with Thalassemia 48 https://www.cdc.gov/ncbddd/thalassemia/webinar-archives.html
84 Remembering Carol Orzel, FOP patient, who donated her skeleton to the 1d the mutter museum.
d2 Interviewed by checkrare after Palovarotene was approved by the FDA and the first and only treatment for FOP.
d5 CME titled "First Do No Harm: Realizing Timely Diagnosis and Treatment for Patients with Fibrodysplasia Ossificans Progressiva"
f4 Endocrinology Spotlight Series: Management of Calcium and Metabolic Bone Disorders Expert Guidance for Challenging Cases
b3 Commentary regarding type 1 diabetes and bone in medpage today
dc Patient Educational Videos at Penn Medicine: Osteoporosis Medications differences between anti resorptive and osteo anabolic therapies
9c Official website for International Clinical Council on Fibrodysplasia Ossificans Progressiva
e4 Penn bone Center featured in Penn Medicine Women's health newsletter
97 Podcast on Women's Health in FOP
b8 What Clinicians Need to Know About Fibrodysplasia Ossificans Progressiva, Interview with CheckRare
80 International Fibrodysplasia Ossificans Progressiva Association
c
5
21
8a Webinar on COVID-19 vaccinations in FOP patients
bf Patient educational Video for Penn Medicine: Journey of osteoporotic patients through falls and fractures
c1 Penn Bone Center
a4 Global CME on treatment considerations in Fibrodysplasia Ossificans Progressiva (FOP)
9e Patient Educational Video at Penn Medicine: Osteoporosis Myths and Facts
be Interviewed for a Penn primary care podcast to discuss osteoporosis
a4 Penn Primary Care Podcast discussing osteoporosis 4e Hosted by Drs Amber Bird, Deepa Rani Nandiwada and Mona Al Mukaddam
a4 Webinar for BMT organization on "Bone Health after Transplant"
a6 CureTalk@penn: How Is Fibrodysplasia Ossificans Progressiva (FOP) First Detected?
121 Report on a patient with a rare bone disease correctly diagnosed at the Penn Bone Center
cd CDC sponsored virtual grand round on evaluation and management of bone health in patients with Thalassemia 48 https://www.cdc.gov/ncbddd/thalassemia/webinar-archives.html
84 Remembering Carol Orzel, FOP patient, who donated her skeleton to the 1d the mutter museum.
d2 Interviewed by checkrare after Palovarotene was approved by the FDA and the first and only treatment for FOP.
d5 CME titled "First Do No Harm: Realizing Timely Diagnosis and Treatment for Patients with Fibrodysplasia Ossificans Progressiva"
f4 Endocrinology Spotlight Series: Management of Calcium and Metabolic Bone Disorders Expert Guidance for Challenging Cases
b3 Commentary regarding type 1 diabetes and bone in medpage today
dc Patient Educational Videos at Penn Medicine: Osteoporosis Medications differences between anti resorptive and osteo anabolic therapies
9c Official website for International Clinical Council on Fibrodysplasia Ossificans Progressiva
e4 Penn bone Center featured in Penn Medicine Women's health newsletter
97 Podcast on Women's Health in FOP
b8 What Clinicians Need to Know About Fibrodysplasia Ossificans Progressiva, Interview with CheckRare
80 International Fibrodysplasia Ossificans Progressiva Association
c
1f
Post-Graduate Training
24 78 Intern, Internal Medicine, American University of Beirut - Medical Center, Beirut, Lebanon, 2005-2006.
24 77 Clinical Research Fellow, American University of Beirut - Medical Center, Beirut, Lebanon, 2006-2007.
24 7f Intern and Resident, Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, 2007-2010.
24 86 Fellow, University of Pennsylvania, Division of Endocrinology, Diabetes and Metabolism, Philadelphia, PA, 2010-2013.
24 ab Post-Doctoral Fellow and Clinical Associate, University of Pennsylvania, Division of Endocrinology, Diabetes and Metabolism, Philadelphia, PA, 2013-2014.
c
3
25
24 78 Intern, Internal Medicine, American University of Beirut - Medical Center, Beirut, Lebanon, 2005-2006.
24 77 Clinical Research Fellow, American University of Beirut - Medical Center, Beirut, Lebanon, 2006-2007.
24 7f Intern and Resident, Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, 2007-2010.
24 86 Fellow, University of Pennsylvania, Division of Endocrinology, Diabetes and Metabolism, Philadelphia, PA, 2010-2013.
24 ab Post-Doctoral Fellow and Clinical Associate, University of Pennsylvania, Division of Endocrinology, Diabetes and Metabolism, Philadelphia, PA, 2013-2014.
c
17
Certifications
28 5c American Board of Internal Medicine, not maintaining certification., 2010.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2012.
28 6c The International Society for Clinical Densitometry, not maintaining certification., 2012.
c
3
8d
Permanent link28 5c American Board of Internal Medicine, not maintaining certification., 2010.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2012.
28 6c The International Society for Clinical Densitometry, not maintaining certification., 2012.
c
2 29
21
1e
1d
24
5e
71
87 Evaluation of osteoporosis and the effects of treatment/diseases on "bone quality" using high resolution imaging of bone (uMRI).
e 29
27
Description of Clinical Expertise
15e Rare bone disease with expertise in Fibrodysplasia Ossificans Progressiva and hypophosphatasia. Metabolic bone and calcium disorders including osteoporosis, Paget's disease, hypo- and hyper-parathyroidism as well as bone diseases related to transplant, medications (example aromatase inhibitors and glucocorticoids) and iron overload.71
Description of Research Expertise
62 Clinical research in Fibrodysplasia Ossificans Progressiva and hypophosphatasia.87 Evaluation of osteoporosis and the effects of treatment/diseases on "bone quality" using high resolution imaging of bone (uMRI).
e 29
23
cc Cassandra Crompton, Kassidy Baum, Michael Silvey, Mona Al Mukaddam: Comparison of Forteo® and PF708 teriparatide on improvements in bone mineral density 2 38 JAPhA Pharmacotherapy Jan 2026.
170 Scott C, Al Mukaddam M, Davis M, De Cunto CL, Hsiao EC, Pignolo RJ, Schwegler O, Artyomenko A, Croskery K, Hanman K, Sanchot B, Warnants E, Kaplan FS : Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review. Ther Adv Musculoskelet Dis. Dec 2025.
fc Rahaf Sultan and Mona Al Mukaddam : "Bone Health and Prevalence of Low Bone Density/Osteoporosis in Gender Diverse Adults; A retrospective Study" ASBMR annual meeting Sept 2025.
27f Frederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, Alberto Hidalgo Bravo, Matthew Brown, Amanda Cali, Tae-Joon Cho, Corrie Crowe, Carmen L De Cunto, Patricia L R Delai, Robert J Diecidue, Elisabeth Marelise W Eekhoff, Lisa Friedlander, Clive S Friedman, Zvi Grunwald, Nobuhiko Haga, Edward C Hsiao, Richard Keen, Joseph A Kitterman, Charles Levy, Vrisha Madhuri, Rolf Morhart, J Coen Netelenbos, Christiaan Scott, Eileen M Shore, Michael Zasloff, Keqin Zhang, Robert J Pignolo: Medical Guidelines for Fibrodysplasia Ossificans Progressiva. JBMR Plus Sept 2025.
fa Marah Alsayed Hasan, Mona Al Mukaddam : Burosumab Use in FGF-23 Mediated Hypophosphatemia in McCune Albright Syndrome. Poster Presentation at the Annual ASBMR meeting Sept 2025.
e6 Cassandra Crompton, PharmD; Kassidy Baum, PharmD; Michael Silvey, PharmD; Mona Al Mukaddam, MD, MS: Comparison of Forteo® and Teriparatide on Improvements in Bone Mineral Density 2 5d Poster Presentation at Endocrine Society Annual Meeting July 2025.
da Javier Ocampo Mascaro, Katherine Toder, Staci Kallish, Mona Al Mukaddam : Applying the Hypophosphatasia Diagnostic Criteria in a Patient Cohort at the Penn Bone Center 2 5a Post Presentation at Endocrine Society Annual Meeting July 2025.
94 Bassam AlHamer and Mona Al Mukaddam : Silicosis Induced Hypercalcemia Treated with Ketoconazole 2 5a Post Presentation at Endocrine Society Annual Meeting July 2025.
169 Natalie Dapas, Mona Al Mukaddam, Hamdee Attallah, Carrie M. Burns, Robert Jones, Julia Kharlip, Kristen Noelle Kobaly, Serena Cardillo: Creation of Educational Resources to Improve Endocrine Fellow Outpatient Curriculum. Poster Presentation at Endocrine Society Annual Meeting July 2025.
2c
7
1d
1f
Selected Publications
114 Rahaf Sultan, Valerie Bai, Mona Al Mukaddam: Approach to Hypercalcemia in a Patient Taking Immune Checkpoint Inhibitor Therapy for Breast Cancer. Endocrine Society Annual Meeting, Chicago, IL June 2026.cc Cassandra Crompton, Kassidy Baum, Michael Silvey, Mona Al Mukaddam: Comparison of Forteo® and PF708 teriparatide on improvements in bone mineral density 2 38 JAPhA Pharmacotherapy Jan 2026.
170 Scott C, Al Mukaddam M, Davis M, De Cunto CL, Hsiao EC, Pignolo RJ, Schwegler O, Artyomenko A, Croskery K, Hanman K, Sanchot B, Warnants E, Kaplan FS : Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review. Ther Adv Musculoskelet Dis. Dec 2025.
fc Rahaf Sultan and Mona Al Mukaddam : "Bone Health and Prevalence of Low Bone Density/Osteoporosis in Gender Diverse Adults; A retrospective Study" ASBMR annual meeting Sept 2025.
27f Frederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, Alberto Hidalgo Bravo, Matthew Brown, Amanda Cali, Tae-Joon Cho, Corrie Crowe, Carmen L De Cunto, Patricia L R Delai, Robert J Diecidue, Elisabeth Marelise W Eekhoff, Lisa Friedlander, Clive S Friedman, Zvi Grunwald, Nobuhiko Haga, Edward C Hsiao, Richard Keen, Joseph A Kitterman, Charles Levy, Vrisha Madhuri, Rolf Morhart, J Coen Netelenbos, Christiaan Scott, Eileen M Shore, Michael Zasloff, Keqin Zhang, Robert J Pignolo: Medical Guidelines for Fibrodysplasia Ossificans Progressiva. JBMR Plus Sept 2025.
fa Marah Alsayed Hasan, Mona Al Mukaddam : Burosumab Use in FGF-23 Mediated Hypophosphatemia in McCune Albright Syndrome. Poster Presentation at the Annual ASBMR meeting Sept 2025.
e6 Cassandra Crompton, PharmD; Kassidy Baum, PharmD; Michael Silvey, PharmD; Mona Al Mukaddam, MD, MS: Comparison of Forteo® and Teriparatide on Improvements in Bone Mineral Density 2 5d Poster Presentation at Endocrine Society Annual Meeting July 2025.
da Javier Ocampo Mascaro, Katherine Toder, Staci Kallish, Mona Al Mukaddam : Applying the Hypophosphatasia Diagnostic Criteria in a Patient Cohort at the Penn Bone Center 2 5a Post Presentation at Endocrine Society Annual Meeting July 2025.
94 Bassam AlHamer and Mona Al Mukaddam : Silicosis Induced Hypercalcemia Treated with Ketoconazole 2 5a Post Presentation at Endocrine Society Annual Meeting July 2025.
169 Natalie Dapas, Mona Al Mukaddam, Hamdee Attallah, Carrie M. Burns, Robert Jones, Julia Kharlip, Kristen Noelle Kobaly, Serena Cardillo: Creation of Educational Resources to Improve Endocrine Fellow Outpatient Curriculum. Poster Presentation at Endocrine Society Annual Meeting July 2025.
2c